approval · primary record
BELANTAMAB MAFODOTIN-BLMF
FDA · BLA · 2025-10-23
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-23 |
| Brand | BLENREP |
| Sponsor | GLAXOSMITHKLINE LLC |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:43.444Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BELANTAMAB MAFODOTIN-BLMF:2025-10-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.